These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1723454

  • 21. Effectiveness of nitrendipine, 20 mg once daily in the management of hypertension in general practice.
    Ansquer JC, Boussac I, Triaud P.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S55-8. PubMed ID: 1723457
    [Abstract] [Full Text] [Related]

  • 22. Nitrendipine in treatment of hypertension.
    Jaroonvesama N.
    J Med Assoc Thai; 1991 May; 74(5):278-82. PubMed ID: 1783876
    [Abstract] [Full Text] [Related]

  • 23. Medium-term effects of betaxolol monotherapy and combination therapy with nitrendipine on lipoprotein and apolipoprotein metabolism in patients with mild to moderate essential hypertension.
    Saku K, Zhang B, Okamoto T, Takeda Y, Liu K, Jimi S, Arakawa K.
    J Hum Hypertens; 1996 Apr; 10(4):263-8. PubMed ID: 8736459
    [Abstract] [Full Text] [Related]

  • 24. Long-term treatment of essential arterial hypertension with nitrendipine.
    Uslenghi E, Minelli M, Bo L, Avogliero G, Amerio S, Rocci R, Borgnino C.
    Clin Ther; 1988 Apr; 10(2):169-77. PubMed ID: 3273864
    [Abstract] [Full Text] [Related]

  • 25. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L, Hiremath, Kerkar PG, Manade VG.
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the efficacy of nilvadipine and nitrendipine on circadian blood pressure.
    Keck M.
    J Cardiovasc Pharmacol; 1992 Mar; 20 Suppl 6():S43-9. PubMed ID: 1283188
    [Abstract] [Full Text] [Related]

  • 27. [Study of the influence of the time of administration on the antihypertensive effect and nitrendipine tolerance in mild to moderate essential hypertensive patients. Value of ambulatory recording of blood pressure on 24 hours].
    Meilhac B, Mallion JM, Carre A, Chanudet X, Poggi L, Gosse P, Dallocchio M.
    Therapie; 1992 Mar; 47(3):205-10. PubMed ID: 1295122
    [Abstract] [Full Text] [Related]

  • 28. Metabolic effects of nitrendipine.
    Paolisso G, Aceto E, Cennamo G, D'Amore A, Varricchio M.
    Clin Ther; 1991 Mar; 13(6):695-8. PubMed ID: 1790544
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of nitrendipine in patients with severe hypertension: a multiclinic study.
    Jain AK, McMahon FG, Ryan JR, Maronde R, Vlachakis N, Mroczek W.
    J Cardiovasc Pharmacol; 1984 Mar; 6 Suppl 7():S1053-9. PubMed ID: 6085366
    [Abstract] [Full Text] [Related]

  • 30. Effectiveness and tolerability of once versus twice daily nitrendipine in the treatment of mild to moderate hypertension. The Canadian Nitrendipine Study Group.
    Bolli P, Cobby J, Handa SP, LaPlante LE, Mukherjee J, Rabin EZ, Strong HA, Wright JM.
    Can J Cardiol; 1991 Mar; 7(2):59-64. PubMed ID: 2049684
    [Abstract] [Full Text] [Related]

  • 31. [Evaluation of the chronic antihypertensive effect of nitrendipine using ambulatory monitoring].
    Rossi L, Tomei R, Carbonieri E, Franceschini L, Zardini P.
    Cardiologia; 1994 Mar; 39(3):187-91. PubMed ID: 8039197
    [Abstract] [Full Text] [Related]

  • 32. [Efficacy and tolerance of a new calcium-channel blocking agent (nitrendipine) in the treatment of arterial hypertension].
    Lopes HF, Silva HB, Bellotti G, Pillegi F.
    Arq Bras Cardiol; 1990 Mar; 54(3):227-9. PubMed ID: 2288512
    [Abstract] [Full Text] [Related]

  • 33. Circadian rhythm of blood pressure and calcium entry blockade: a chronobiologic study with nitrendipine in essential hypertension.
    Mele D, Manfredini R, Amadei GA, Sgobino P, Longhini C, Fersini C.
    J Cardiovasc Pharmacol; 1991 Mar; 18 Suppl 1():S51-4. PubMed ID: 1723456
    [Abstract] [Full Text] [Related]

  • 34. Middle term evaluation of amlodipine vs nitrendipine: efficacy, safety and metabolic effects in elderly hypertensive patients.
    Grandinetti O, Feraco E.
    Clin Exp Hypertens; 1993 Mar; 15 Suppl 1():197-210. PubMed ID: 8513310
    [Abstract] [Full Text] [Related]

  • 35. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
    Nannan ME, Melin JA, Vanbutsele RJ, Lavenne F, Detry JM.
    J Cardiovasc Pharmacol; 1984 Mar; 6 Suppl 7():S1043-8. PubMed ID: 6085364
    [Abstract] [Full Text] [Related]

  • 36. Acute and short-term effects of nitrendipine and diltiazem at rest and during exercise in hypertensive patients.
    Gambini G, Valori C, Bianchi L, Bozza M.
    Clin Ther; 1991 Mar; 13(6):680-6. PubMed ID: 1790542
    [Abstract] [Full Text] [Related]

  • 37. Effects of fosinopril on the blood pressure and lipid profile of patients undergoing heart transplantation.
    Almenar L, Osa A, Palencia M, Flores A, Sánchez E.
    J Heart Lung Transplant; 1997 Apr; 16(4):454-9. PubMed ID: 9154957
    [Abstract] [Full Text] [Related]

  • 38. Humoral and hemodynamic effects of nitrendipine versus clonidine in patients with essential hypertension.
    Stornello M, Valvo EV, Scapellato L, Nazzari M.
    Clin Ther; 1986 Apr; 8(5):510-9. PubMed ID: 3533265
    [Abstract] [Full Text] [Related]

  • 39. [24-hour antihypertensive efficacy of nitrendipine].
    Spritzer N, Medeiros CM, Spritzer TS, Medeiros NK.
    Arq Bras Cardiol; 1990 Jul; 55(1):71-4. PubMed ID: 2073165
    [Abstract] [Full Text] [Related]

  • 40. [Randomized, comparative study to evaluate efficacy and safety of doxazosin versus nitrendipine in the treatment of mild to moderate hypertension].
    Sanz Guajardo D, Espejo Martínez J.
    An Med Interna; 1997 Jan; 14(1):15-9. PubMed ID: 9091027
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.